Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Williams Prices Offering Of 26 Mln Shares At $30.59/Shr - Quick Facts

Williams (WMB: Quote) said it has priced a public offering of 26.0 million common shares at $30.59 per share. Also, the company has granted the underwriters a 30-day option to buy up to an additional 3.90 million shares. The offering may close on April 4, 2012.

Williams plans to use the net proceeds from the offering to purchase additional Williams Partners L.P. (WPZ) common units in connection with the financing of the acquisition by Williams Partners L.P. of Caiman Eastern Midstream, LLC that was already announced.

Barclays, Citigroup, UBS Investment Bank, Deutsche Bank Securities and J.P. Morgan are acting as joint book-running managers.

Click here to receive FREE breaking news email alerts for Williams Cos. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
United Nations Secretary-General Ban Ki-moon on Tuesday urged both Israelis and Palestinians to stop the fighting that has been raging for the past two weeks in the Gaza Strip, and pleaded with the two sides to return to dialogue with the aim of addressing the underlying causes of the repeated cycles... After moving notably higher in early trading on Tuesday, stocks continued to perform well throughout the session. The gains on the day offset the modest weakness that was seen in the previous session, extending the recent back-and-forth movement by the markets. Two federal appeals courts have issued contradictory rulings over the federal government's ability to provide subsidies under Obamacare, suggesting that the future of President Barack Obama's healthcare law could once again end up in the hands of the U.S. Supreme Court.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.